TB Vaccines Pipeline
- Viral Vector
- Protein/Adjuvant
- Mycobacterial – Killed Whole Cell or Extract
- Mycobacterial – Live Attenuated
Revised 7 October 2019
Anhui Zhifei Longcom
McMaster, CanSino
Univ of Oxford
Archivel Farma, S.L
Biofabri, TBVI, Zaragosa
IDRI, Wellcome Trust, Quratis
RIBSP
Dartmouth, GHIT
GSK
SSI, IAVI, EDCTP, Valneva
Gates Medical Research Institute (GMRI)
Anhui Zhifei Longcom
SII, Max Planck, VPM, TBVI
(Phase 2/3)
ICMR, Cadila Pharmaceuticals
TB Vaccine Candidate Submission Form
The WGNV is compiling information on TB vaccine candidates in development, from discovery and proof-of-concept in animal models through to Phase 3 clinical trials. As information is compiled, a more comprehensive and inclusive pipeline will be developed and will be made available for public use. To submit a vaccine candidate for inclusion in this pipeline or to provide an updated status on a candidate already included in the pipeline, please complete and submit the form below. By submitting information through this platform, you agree to have the information shared for public viewing and use. Please do not submit confidential information or information that is not yet available for the public.
Get Involved
If you would like to learn more about the WGNV and how you can be, please contact us!
Contact Us